COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 194 participants.

Also called NCT03156816

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 194 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03156816
  • EudraCT 2017-004090-13
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03156816. Randomized; quadruple masking; primary purpose treatment. Start 2018-07-23 (actual); primary completion 2020-11-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction
Acronym
COVERT-MI
Intervention (Drug)
Colchicine group (experimental arm)
Intervention (Drug)
Placebo group (control arm)
Lead sponsor
Hospices Civils de Lyon (class: other)

Record details

Record id
cardio:ct-nct03156816
Content hash
a30e0a03cc6ecad0b6a71300c5016a28bea6dff2a8ee0265ff09345d871eecc7